CJC-1295 with DAC
A GHRH 1-29 analogue carrying a drug-affinity-complex modification for longer persistence
≥99% HPLCThe C-terminal 176-191 stretch of human growth hormone, studied for fragment-specific receptor interactions and metabolic pathways.
In stock, dispatched same day before 16:00
Sold for research purposes only. For in-vitro laboratory research. Not a medicine and not for human or animal consumption. Supplied to qualified individuals aged 18 and over; you confirm this at checkout.
HGH Frag 176-191 is the C-terminal stretch of human growth hormone, a 16-residue peptide with the sequence YLRIVQCRSVEGSCGF. It is studied in vitro and in preclinical models for fragment-specific receptor interactions and metabolic pathways. Supplied at 2mg as a lyophilised powder for in-vitro laboratory research only.
The 176-191 region sits at the C-terminus of growth hormone. It has been examined as a fragment that may retain some of the metabolic activity reported for the full protein while lacking its growth-promoting and insulin-antagonising effects. The literature describes experiments in adipocyte models that measure lipolysis and lipogenesis. The mechanism is not settled, some reports point to signalling independent of the classical growth hormone receptor, and published findings differ between models.
Researchers use the fragment in adipocyte culture assays that follow glycerol release and lipid uptake, in receptor-binding comparisons with intact growth hormone, and in peptide stability studies that follow the two cysteines and their disulfide behaviour. It is often compared with AOD9604, a closely related fragment analogue. The compound is supplied as a lyophilised powder.
Store the lyophilised powder cold, dry and protected from light, and let the vial reach room temperature before opening. Reconstitute with an appropriate laboratory diluent, aliquot, and keep reconstituted material cold.
Each lot of HGH Frag 176-191 is released with a certificate recording identity and purity. Enter the lot number printed on your vial on the lab testing page to view it.
Both are based on the C-terminal 176-191 region of human growth hormone. AOD9604 is a modified analogue of this fragment and is listed separately, and the two are often compared in fragment-specific metabolic studies.
It is supplied as a lyophilised powder in a 2mg vial. The sequence contains two cysteines, so keep the material cold, dry and away from light and moisture.
No. It is supplied strictly for in-vitro laboratory research. It is not a medicine, food or supplement, and it is not for human or animal use. Buyers must be aged 18 or over.